A cost-effectiveness analysis of neonatal ECMO using existing evidence

Area of Science:

• Neonatal intensive care
• Health economics
• Medical technology assessment

Background:

• Extracorporeal membrane oxygenation (ECMO) is an advanced life support technique for neonates with severe cardiorespiratory failure.
• The U.K. ECMO Trial aims to evaluate the effectiveness and cost-effectiveness of neonatal ECMO.
• Existing evidence on ECMO's costs and effectiveness is limited and inconclusive.

Purpose of the Study:

• To prepare for a cost-effectiveness analysis of neonatal ECMO.
• To systematically evaluate the current evidence base regarding the costs and effectiveness of neonatal ECMO.

Main Methods:

• A comprehensive review of existing literature on the costs and effectiveness of neonatal ECMO was conducted.
• Evidence synthesis and critical appraisal of relevant studies were performed.

Main Results:

• Neonatal ECMO is associated with higher costs compared to conventional treatment.
• The effectiveness of ECMO relative to conventional treatment remains uncertain, with evidence suggesting potential benefits or drawbacks.
• Current data do not support the routine implementation of ECMO prior to the availability of U.K. ECMO Trial results.

Conclusions:

• The decision to introduce neonatal ECMO should be deferred until definitive trial results are available.
• Further research and robust clinical trial data are essential for informed decision-making regarding neonatal ECMO.
• A thorough cost-effectiveness analysis requires comprehensive data on both costs and long-term outcomes.